Clinical Trials Browser

Phase 2 × tivozanib × Sarcoma × Clear all

NCT01782313 2019-09-09

A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas

Phase 2 Completed

58 enrolled 13 charts

Sarcoma